{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:51:07Z","timestamp":1775487067740,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.vaccine.2006.03.078","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T17:42:46Z","timestamp":1145468566000},"page":"5211-5219","source":"Crossref","is-referenced-by-count":40,"title":["Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice"],"prefix":"10.1016","volume":"24","author":[{"given":"Akram A.","family":"Da\u2019Dara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Lautsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Novitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tun-Hou","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Essex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald A.","family":"Harn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9220","key":"10.1016\/j.vaccine.2006.03.078_bib1","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(00)02360-6","article-title":"Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?","volume":"355","author":"Esparza","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.078_bib2","first-page":"427","article-title":"State of the HIV pandemic","volume":"1","author":"Essex","year":"1998","journal-title":"J Hum Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00002030-199706000-00002","article-title":"The puzzle of HIV-1 subtypes in Africa","volume":"11","author":"Janssens","year":"1997","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.078_bib4","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.71.7.5441-5448.1997","article-title":"Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe","volume":"71","author":"Shafer","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.03.078_bib5","volume":"16","author":"Staneki","year":"1996"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2006.03.078_bib6","first-page":"S13","article-title":"The molecular epidemiology of HIV in Asia","volume":"8","author":"Weniger","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2006.03.078_bib7","unstructured":"UNAIDS. Posting Update. AIDS epedimic update. December, 2001."},{"key":"10.1016\/j.vaccine.2006.03.078_bib8","unstructured":"UNAIDS. Programme Coordinating Board. Ninth Meeting. Report of the Executive Director. 2000."},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2006.03.078_bib9","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/00002030-200317004-00008","article-title":"Role of neutralizing antibodies in HIV infection","volume":"17","author":"Haigwood","year":"2003","journal-title":"AIDS"},{"issue":"5730","key":"10.1016\/j.vaccine.2006.03.078_bib10","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1126\/science.1114854","article-title":"Immunology close to the edge: neutralizing the HIV-1 envelope","volume":"308","author":"Nabel","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.078_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0952-7915(02)00362-X","article-title":"Neutralizing antibodies against HIV\u2014back in the major leagues?","volume":"14","author":"Ferrantelli","year":"2002","journal-title":"Curr Opin Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2006.03.078_bib12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0264-410X(02)00074-9","article-title":"HIV vaccine strategies","volume":"20","author":"Nabel","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nm0605-593","article-title":"Neutralizing antibodies take a swipe at HIV in vivo","volume":"11","author":"Montefiori","year":"2005","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.vaccine.2006.03.078_bib14","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1128\/JVI.75.13.5879-5890.2001","article-title":"Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques","volume":"75","author":"Montefiori","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.03.078_bib15","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1128\/JVI.75.5.2462-2467.2001","article-title":"Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys","volume":"75","author":"Barouch","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.078_bib16","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.078_bib17","first-page":"25","article-title":"Development of prophylactic AIDS vaccines: the current state of affairs","volume":"5","author":"Hanke","year":"2003","journal-title":"Curr Opin Mol Ther"},{"issue":"20","key":"10.1016\/j.vaccine.2006.03.078_bib18","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1128\/JVI.76.20.10155-10168.2002","article-title":"Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C","volume":"76","author":"Novitsky","year":"2002","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.078_bib19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nm0703-874","article-title":"HIV vaccines 1983\u20132003","volume":"9","author":"McMichael","year":"2003","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm1244","article-title":"Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies","volume":"11","author":"Trkola","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2006.03.078_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.med.54.101601.152349","article-title":"Progress toward an HIV vaccine","volume":"56","author":"Letvin","year":"2005","journal-title":"Annu Rev Med"},{"issue":"5403","key":"10.1016\/j.vaccine.2006.03.078_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"issue":"5491","key":"10.1016\/j.vaccine.2006.03.078_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.290.5491.486","article-title":"Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination","volume":"290","author":"Barouch","year":"2000","journal-title":"Science"},{"issue":"6869","key":"10.1016\/j.vaccine.2006.03.078_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.078_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1568005054201571","article-title":"CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection?","volume":"5","author":"Brown","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.078_bib26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0169-4758(97)01144-7","article-title":"The global burden of intestinal nematode infections\u201450 years on","volume":"13","author":"Chan","year":"1997","journal-title":"Parasitol Today"},{"issue":"12","key":"10.1016\/j.vaccine.2006.03.078_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pt.2003.10.002","article-title":"Soil-transmitted helminth infections: updating the global picture","volume":"19","author":"de Silva","year":"2003","journal-title":"Trends Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.078_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1517\/14656566.5.2.263","article-title":"Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control","volume":"5","author":"Utzinger","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2006.03.078_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","article-title":"Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa","volume":"86","author":"van der Werf","year":"2003","journal-title":"Acta Trop"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/382077","article-title":"Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project","volume":"38","author":"Hotez","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/eji.1830260633","article-title":"Evidence of a T helper type 2 activation in human schistosomiasis","volume":"26","author":"Araujo","year":"1996","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.078_bib32","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.146.4.1322","article-title":"Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni","volume":"146","author":"Grzych","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.03.078_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.0105-2896.2004.00187.x","article-title":"Th2 response polarization during infection with the helminth parasite Schistosoma mansoni","volume":"201","author":"Pearce","year":"2004","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.078_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.173.1.159","article-title":"Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth Schistosoma mansoni","volume":"173","author":"Pearce","year":"1991","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.078_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-3024.1995.tb01002.x","article-title":"Specific T cell unresponsiveness in human filariasis: diversity in underlying mechanisms","volume":"17","author":"Sartono","year":"1995","journal-title":"Parasite Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.078_bib36","first-page":"1619","article-title":"The absence of gamma-interferon production of S. mansoni antigens in patients with schistosomiasis","volume":"27","author":"Araujo","year":"1994","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"10.1016\/j.vaccine.2006.03.078_bib37","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1172\/JCI112982","article-title":"Parasite-specific anergy in human filariasis Insights after analysis of parasite antigen-driven lymphokine production","volume":"79","author":"Nutman","year":"1987","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.078_bib38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.173.2.1224","article-title":"CD25+ CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development","volume":"173","author":"McKee","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.078_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0167-5699(99)01499-1","article-title":"Can eradication of helminthic infections change the face of AIDS and tuberculosis?","volume":"20","author":"Bentwich","year":"1999","journal-title":"Immunol Today"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.078_bib40","first-page":"1368","article-title":"Eradication of helminthic infections may be essential for successful vaccination against HIV and tuberculosis","volume":"78","author":"Borkow","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.078_bib41","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1073\/pnas.90.3.948","article-title":"Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance","volume":"90","author":"Actor","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.078_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/infdis\/173.1.269","article-title":"Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni","volume":"173","author":"Sabin","year":"1996","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.078_bib43","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1128\/IAI.67.11.5951-5957.1999","article-title":"Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response","volume":"67","author":"Cooper","year":"1999","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib44","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/IAI.73.6.3531-3539.2005","article-title":"Impairment of protective immunity to blood-stage malaria by concurrent nematode infection","volume":"73","author":"Su","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.078_bib45","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/IAI.69.3.1574-1580.2001","article-title":"Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR","volume":"69","author":"Cooper","year":"2001","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2006.03.078_bib46","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.4049\/jimmunol.148.10.3264","article-title":"Infection with Schistosoma mansoni alters Th1\/Th2 cytokine responses to a non-parasite antigen","volume":"148","author":"Kullberg","year":"1992","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib47","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1158\/1055-9965.EPI-05-0095","article-title":"Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis","volume":"14","author":"Whary","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.078_bib48","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1086\/317623","article-title":"Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro","volume":"182","author":"Gopinath","year":"2000","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.078_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-3024.2002.00473.x","article-title":"Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages","volume":"24","author":"La Flamme","year":"2002","journal-title":"Parasite Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2006.03.078_bib50","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/01.aids.0000189857.51935.0b","article-title":"Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques","volume":"19","author":"Chenine","year":"2005","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.vaccine.2006.03.078_bib51","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1128\/JVI.70.10.7335-7340.1996","article-title":"Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys","volume":"70","author":"Voss","year":"1996","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.078_bib52","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4049\/jimmunol.147.1.320","article-title":"Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys","volume":"147","author":"Miller","year":"1991","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.078_bib53","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.85.9.3105","article-title":"An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes","volume":"85","author":"Takahashi","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2006.03.078_bib54","first-page":"191","article-title":"Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells","volume":"302","author":"Cole","year":"2005","journal-title":"Meth Mol Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.078_bib55","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/JVI.75.3.1339-1347.2001","article-title":"Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays","volume":"75","author":"Goulder","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.078_bib56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-199905070-00005","article-title":"A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals","volume":"13","author":"Larsson","year":"1999","journal-title":"AIDS"},{"issue":"19","key":"10.1016\/j.vaccine.2006.03.078_bib57","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1128\/JVI.75.19.9210-9228.2001","article-title":"Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design","volume":"75","author":"Novitsky","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.03.078_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2005.01.145","article-title":"Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants","author":"Slyker","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.078_bib59","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.4049\/jimmunol.154.4.1973","article-title":"Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule","volume":"154","author":"Takeshita","year":"1995","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.03.078_bib60","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.159.5.1371","article-title":"Schistosoma mansoni Anti-egg monoclonal antibodies protect against cercarial challenge in vivo","volume":"159","author":"Harn","year":"1984","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2006.03.078_bib61","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.4049\/jimmunol.174.8.5119","article-title":"Coinfection with Schistosoma mansoni is associated with decreased HIV-specific cytolysis and increased IL-10 production","volume":"174","author":"McElroy","year":"2005","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.078_bib62","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/1521-4141(200009)30:9<2669::AID-IMMU2669>3.0.CO;2-1","article-title":"Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact","volume":"30","author":"Loke","year":"2000","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.078_bib63","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4049\/jimmunol.173.2.1240","article-title":"Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages","volume":"173","author":"Smith","year":"2004","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.03.078_bib64","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.4049\/jimmunol.167.8.4293","article-title":"A Schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism","volume":"167","author":"Atochina","year":"2001","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.078_bib65","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.4049\/jimmunol.167.9.5294","article-title":"The schistosome oligosaccharide lacto-n-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections","volume":"167","author":"Terrazas","year":"2001","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.078_bib66","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1128\/IAI.70.7.3656-3664.2002","article-title":"Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability","volume":"70","author":"Rodriguez-Sosa","year":"2002","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T04:11:48Z","timestamp":1683432708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":66,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0264410X06003951"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}